Cleared Traditional

K191513 - Altapore Shape

K191513 is the FDA 510(k) clearance for Altapore Shape by Baxter Healthcare Corporation. It is a Class 2 Orthopedic device (product code MQV) cleared through the Traditional 510(k) pathway after a 134-day FDA review.

K191513 · Baxter Healthcare Corporation · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
134d
Days
Class 2
Risk

K191513 is an FDA 510(k) clearance for the Altapore Shape. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on October 19, 2019 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K191513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2019
Decision Date October 19, 2019
Days to Decision 134 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 122d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 232
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K191513.
Altapore
K192363 · Baxter Healthcare Corporation · Jan 2020
Resorbable Mesh Device
K193040 · SeaSpine Orthopedics Corporation · Nov 2019
NuVasive AttraX Putty
K191974 · Nu Vasive, Incorporated · Nov 2019
Sorrento Bone Graft Substitute
K191074 · Xenco Medical, LLC · Sep 2019
Morpheus-C
K190371 · Biogennix, LLC · Aug 2019
BonAlive Granules
K191274 · Bonalive Biomaterials, Ltd. · Aug 2019